Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

10 Jul 2008 07:00

RNS Number : 7381Y
Craneware plc
10 July 2008
 



Craneware plc

("Craneware" or the "Company")

TRADING UPDATE 

10 July 2008 - Craneware plc, (AIM: CRW) a leader in revenue cycle management software solutions for the US healthcare market, is pleased to give an update today on trading during the year to 30 June 2008. 

The Company has performed strongly during the year, exceeding targets set at the time of the IPO in September, culminating in the signing of the two separate agreements with Catholic Healthcare West and Catholic Health East announced within the last month, revenues from which will only be recognised in subsequent years. 

During the year, the management continued to execute on its stated strategy of broadening the Company's customer base signing up 194 new hospitals during the year, resulting in Craneware's software being used in 950 US hospitals up from 801 at the beginning of the year. Renewal rates for multi-year contracts remain above 90%.

In additional to broadening the customer base, the Company also increased customer penetration through the cross-sale of two additional products, Patient Charge Estimator™ and Pharmacy ChargeLink™, which were launched at the end of the 1st half of the year. Over 30% of new hospital wins during the year included at least one of the newly launched products with additional sales made to existing hospital clients ahead of management's expectations. 

The Board is therefore confident of reporting results for the year ended 30 June 2008 in line with expectations. These results will be announced on Tuesday 9 September 2008. 

Keith Neilson, CEO of Craneware, commented, "We are delighted with the strong growth achieved in the year, underlining our position as the leader in revenue cycle management software in the US. We have exceeded our goals as stated at the time of the Company's IPO in September last year, and are confident in our ability to continue to execute upon our strategy in the year ahead." 

For further information, please contact:

Craneware plc

KBC Peel Hunt

ICIS

+44 (0)1506 407 666

+44 (0)20 7418 8900

+44 (0)20 7651 8688

Keith Neilson, CEO

Oliver Scott

Tom Moriarty

Sandy McDougall, CFO

Deon Veldtman

Caroline Evans-Jones

About Craneware

Founded in 1999, Craneware has headquarters in LivingstonScotland, with offices in FloridaArizona and Kansas, employing over 100 staff. Craneware's products, which include the Company's flagship, Chargemaster Toolkit® assist US healthcare providers in reducing billing errors, ensuring the timely and accurate submission of claims and managing compliance risk. More information about Craneware plc and its services can be found on-line at the Company's corporate website, www.craneware.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRLMFTMMTMBPP
Date   Source Headline
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.
15th Apr 20217:00 amRNSBlock listing Interim Review
19th Mar 20211:05 pmRNSDividend Currency Election
1st Mar 20217:00 amRNSInterim Results
20th Jan 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.